Slideshow
-
jardiance-empagliflozin-diabetes-mellitus-drug-101
-
jardiance-empagliflozin-diabetes-mellitus-drug-211
-
jardiance-empagliflozin-diabetes-mellitus-drug-321
-
jardiance-empagliflozin-diabetes-mellitus-drug-431
-
jardiance-empagliflozin-diabetes-mellitus-drug-541
-
jardiance-empagliflozin-diabetes-mellitus-drug-651
-
jardiance-empagliflozin-diabetes-mellitus-drug-761
-
jardiance-empagliflozin-diabetes-mellitus-drug-871
-
jardiance-empagliflozin-diabetes-mellitus-drug-981
-
jardiance-empagliflozin-diabetes-mellitus-drug-109
-
jardiance-empagliflozin-diabetes-mellitus-drug-111
-
jardiance-empagliflozin-diabetes-mellitus-drug-121
-
jardiance-empagliflozin-diabetes-mellitus-drug-131
-
jardiance-empagliflozin-diabetes-mellitus-drug-141
-
jardiance-empagliflozin-diabetes-mellitus-drug-151
-
jardiance-empagliflozin-diabetes-mellitus-drug-161
This slideshow reviews drug information for JARDIANCE (empagliflozin) indicated for the treatment of type 2 diabetes mellitus.
Table of Contents
Slide 3: Indication, Dosage & Administration
Slide 6: Use in Specific Populations
Slide 8: Clinical Pharmacology
Slide 11: Warnings & Precautions
Slide 14: Drug Storage & Supply